ONCORETM is Handa’s proprietary drug delivery technology that was developed to create a new, clinically differentiated class of Tyrosine Kinase Inhibitor (TKI) class of oncology drugs.
The proprietary ONCORETM technology offers a novel solubility profile and allows enhanced bioavailability (molecule specific).
